What You Should Know:
- Neura Health, a virtual neurology clinic raises $11.4M in Series A funding round, bringing the company's total funding to $22M led by the American Heart Association's Go Red for Women Venture Fund, marking the fund’s first-ever investment.
- The funding will be used to advance Neura's mission of making high-quality neurological care accessible to all, accelerating growth with payers and health systems, and expanding into new condition
Read More
neurological conditions
Lys Therapeutics Secures $5M MJFF Grant for Parkinson’s Treatment
What You Should Know:
- Lys Therapeutics, a French biotechnology company, has announced a $5M grant award from The Michael J. Fox Foundation for Parkinson’s Research (MJFF).
- The significant funding, part of MJFF’s Therapeutic Pipeline Program, will accelerate the clinical development of LYS241, a first-in-class monoclonal antibody for the treatment of Parkinson’s disease and other neurodegenerative disorders. The grant will support the completion of preclinical development
Read More
Sevaro Health Secures $39M for AI Powered Virtual Neurology & Workflow Augmentation
What You Should Know:
- Sevaro Health, a company specializing in virtual neurological care secures $39M in Series B funding round led by Valtruis and Intermountain Ventures, with continued support from early investors.
- The new capital will allow Sevaro to accelerate innovation, deepen integrations, and expand its hybrid workforce model to help hospitals address staffing shortages and rising patient demand.
Transform Neurological Care with AI and Virtual Solutions
At the
Read More
ARC and Revealense Collaborate on Joint Venture to Deliver At-Home AI-Based Neurological Diagnostics
What You Should Know:
- ARC, the innovation arm of the world-renowned Sheba Medical Center, and Revealense, a creator of a neurological-AI engine, have announced a joint venture.
- The collaboration will focus on delivering an advanced neurological diagnostic solution that uses a standard webcam to provide precise, clinically validated diagnoses for a wide range of neurological, cognitive, and developmental conditions in a patient's home.
Addressing a Major Clinical
Read More
Preventive Neurology: A Game-Changer for Alzheimer’s and Parkinson’s
Hundreds of millions of people worldwide live with a high risk of developing Alzheimer’s Disease (AD). They display no cognitive symptoms but harbor insidious genetic markers of AD-related brain changes.
Simon Nicholls was one of these people. After testing positive for two copies of the ApoE4 gene and concerning blood-based biomarkers for AD, Simon wanted to take control of his health. With two children at home and lots of life left to live, he came to us
Read More
Cedars-Sinai and OSE Co-Invest $2M in Neurology Care Startup Neu Health
What You Should Know:
- Cedars-Sinai Intellectual Property Company and Oxford Science Enterprises (OSE) have announced a strategic partnership to co-invest in and support the development of digital health startups.
- To kick off the partnership, Cedars-Sinai and OSE have co-invested $2 million in Neu Health, a University of Oxford spin-out company that has developed a digital neurology care platform. Neu Health's platform uses a smartphone app and AI to track and analyze
Read More
Omniscient Secures Series C Funding to Expand AI-Powered Brain Mapping
What You Should Know:
- Omniscient (o8t®), a Sydney, Australia-based global leader in applying AI to unlock the secrets of the human brain, announced today the successful conclusion of its Series C funding round. This round brings the company's total capital raised to US$60M , marking a significant milestone in its growth trajectory.
- The funding round highlights the confidence of prominent Australian investors, including Will Vicars and Gina Rinehart, in Omniscient's vision and
Read More
OM1 Launches Parkinson’s Disease Real-World Datasets for Neuroscience
What You Should Know:
Today, OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.OM1’s Mental Health & Neuroscience Real-World Data Network, which already includes robust datasets focused on Major Depressive Disorder, Multiple Sclerosis, Bipolar Disorder I and Schizophrenia, will further expand to include Alzheimer’s Disease in the coming months.
Parkinson’s Disease Premium Dataset
Nearly
Read More
Behavidence Raises $4.3M to Expand AI-Driven Psychiatric & Neurological Disorders Monitoring
What You Should Know:
- Behavidence, a behavioral health company that monitors psychiatric and neurological disorders using artificial intelligence, announced a $4.3M seed round led by Welltech Ventures, featuring Arc Impact and Longevity Ventures.
- Founded in 2020, Behavidence offers multiple digital phenotyping models that can predict disorders such as depression, anxiety, ADHD and more. These digital phenotyping solutions have been adopted by health organizations, tech, commercial and
Read More
From Analog to Digital Neurology: 3 Steps to Better Inform Patient Care
The field of neurology is at an inflection point. With a growing aging population, neurologists are facing an increasing number of patients needing care, and the pent-up demand for services due to COVID-19 only exacerbates this issue. The pressure on neurologists is enormous, with surveys indicating excessive stress caused by inefficient workflow and mounting paperwork 1,2. It is becoming increasingly clear that the traditional analog neurological exam and referral system is overwhelmed, and
Read More
